Regions :: North America :: U.S.
Merged Cambridge Major and AAIPharma appoint former Lonza executive as new CEO
11:22 AM MDT | July 8, 2014 | Deepti Ramesh
Cambridge Major Laboratories (CML; Germantown, WI), a producer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs); and AAIPharma Services (Wilmington, NC), a provider of contract services that support all phases of drug development, say that they have appointed Stephan Kutzer as new CEO, effective 1 August. CML and AAIPharma merged in October 2013. The merged company is a portfolio company of private equity firm American Capital (Bethesda, MD). Kutzer will succeed Patrick Walsh, who left the company in April. Most recently, Kutzer served...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee